Discovery of a new mitochondria permeability transition pore (mPTP) inhibitor based on gallic acid

References

• Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 2011;435:297–312.
   PubMed Web of Science ®Google Scholar
• Smith RA, Hartley RC, Cocheme HM, Murphy MP. Mitochondrial pharmacology. Trends Pharm Sci 2012;33:341–52.
   PubMed Web of Science ®Google Scholar
• James AM, Collins Y, Logan A, Murphy MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 2012;23:429–34.
   PubMed Web of Science ®Google Scholar
• Terman A, Dalen H, Eaton JW, et al. Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover. Ann NY Acad Sci 2004;1019:70–7.
   PubMed Web of Science ®Google Scholar
• Edeas M, Weissig V. Targeting mitochondria: strategies, innovations and challenges: the future of medicine will come through mitochondria. Mitochondrion 2013;13:389–90.
   PubMed Web of Science ®Google Scholar
• Rohlena J, Dong LF, Neuzil J. Targeting the mitochondrial electron transport chain complexes for the induction of apoptosis and cancer treatment. Curr Pharm Biotechnol 2013;14:377–89.
   PubMed Web of Science ®Google Scholar
• Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Ann Rev Pharmacol Toxicol 2007;47:629–56.
   PubMed Web of Science ®Google Scholar
• Andreux PA, Houtkooper RH, Auwerx J. Pharmacological approaches to restore mitochondrial function. Nat Rev Drug Discov 2013;12:465–83.
   PubMed Web of Science ®Google Scholar
• Parikh S, Saneto R, Falk MJ, et al. A modern approach to the treatment of mitochondrial disease. Curr Treat Options Neurol 2009;11:414–30.
   PubMed Web of Science ®Google Scholar
• Apostolova N, Victor VM. Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid Redox Signal 2015;22:686–729.
   PubMed Web of Science ®Google Scholar
• Benfeito S, Oliveira C, Soares P, et al. Antioxidant therapy: still in search of the ‘magic bullet′. Mitochondrion 2013;13:427–35.
   PubMed Web of Science ®Google Scholar
• Badhani B, Sharma N, Kakkar R. Gallic acid: a versatile antioxidant with promising therapeutic and industrial applications. RSC Adv 2015;5:27540–57.
   Web of Science ®Google Scholar
• Fazary AE, Taha M, Ju YH. Iron complexation studies of gallic acid. J Chem Eng Data 2009;54:35–42.
   Web of Science ®Google Scholar
• Wu S, Cao Q, Wang X, et al. Design, synthesis and biological evaluation of mitochondria targeting theranostic agents. Chem Commun (Camb) 2014;50:8919–22.
   PubMed Web of Science ®Google Scholar
• Teixeira J, Soares P, Benfeito S, et al. Rational discovery and development of a mitochondria-targeted antioxidant based on cinnamic acid scaffold. Free Radic Res 2012;46:600–11.
   PubMed Web of Science ®Google Scholar
• Smith RA, Murphy MP. Mitochondria-targeted antioxidants as therapies. Discov Med 2011;11:106–14.
   PubMed Web of Science ®Google Scholar
• Teixeira J, Oliveira C, Amorim R, et al. Development of hydroxybenzoic-based platforms as a solution to deliver dietary antioxidants to mitochondria. Sci Rep 2017;7:6842.
   PubMed Web of Science ®Google Scholar
• Teixeira J, Cagide F, Benfeito S, et al. Development of a mitochondriotropic antioxidant based on caffeic acid: proof of concept on cellular and mitochondrial oxidative stress models. J Med Chem 2017;60:7084–98.
   PubMed Web of Science ®Google Scholar
• Serafim TL, Carvalho FS, Marques MP, et al. Lipophilic caffeic and ferulic acid derivatives presenting cytotoxicity against human breast cancer cells. Chem Res Toxicol 2011;24:763–74.
   PubMed Web of Science ®Google Scholar
• Gornall AG, Bardawill CJ, David MM. Determination of serum proteins by means of the biuret reaction. J Biol Chem 1949;177:751–66.
   PubMed Web of Science ®Google Scholar
• Asin-Cayuela J, Manas AR, James AM, et al. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Lett 2004;571:9–16.
   PubMed Web of Science ®Google Scholar
• Akerman KE, Wikstrom MK. Safranine as a probe of the mitochondrial membrane potential. FEBS Lett 1976;68:191–7.
   PubMed Web of Science ®Google Scholar
• Kowaltowski AJ, Castilho RF. Ca2+ acting at the external side of the inner mitochondrial membrane can stimulate mitochondrial permeability transition induced by phenylarsine oxide. Biochim Biophys Acta 1997;1322:221–9.
   PubMed Web of Science ®Google Scholar
• Soriano ME, Nicolosi L, Bernardi P. Desensitization of the permeability transition pore by cyclosporin a prevents activation of the mitochondrial apoptotic pathway and liver damage by tumor necrosis factor-alpha. J Biol Chem 2004;279:36803–8.
   PubMed Web of Science ®Google Scholar
• Corominas-Faja B, Santangelo E, Cuyas E, et al. Computer-aided discovery of biological activity spectra for anti-aging and anti-cancer olive oil oleuropeins. Aging 2014;6:731–41.
   PubMedGoogle Scholar
• Biasutto L, Mattarei A, Marotta E, et al. Development of mitochondria-targeted derivatives of resveratrol. Bioorg Med Chem Lett 2008;18:5594–7.
   PubMed Web of Science ®Google Scholar
• Mattarei A, Biasutto L, Marotta E, et al. A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols. Chembiochem 2008;9:2633–42.
   PubMed Web of Science ®Google Scholar
• Reddy CA, Somepalli V, Golakoti T, et al. Mitochondrial-targeted curcuminoids: a strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS One 2014;9:e89351.
   PubMed Web of Science ®Google Scholar
• Jayakumar S, Patwardhan RS, Pal D, et al. Mitochondrial targeted curcumin exhibits anticancer effects through disruption of mitochondrial redox and modulation of TrxR2 activity. Free Radic Biol Med 2017;113:530–8.
   PubMed Web of Science ®Google Scholar
• Sassi N, Biasutto L, Mattarei A, et al. Cytotoxicity of a mitochondriotropic quercetin derivative: mechanisms. Biochim Biophys Acta 2012;1817:1095–106.
   PubMed Web of Science ®Google Scholar
• Sassi N, Mattarei A, Azzolini M, et al. Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants. Curr Pharm Des 2014;20:172–9.
   PubMed Web of Science ®Google Scholar
• Kamo N, Muratsugu M, Hongoh R, Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Memb Biol 1979;49:105–21.
   PubMed Web of Science ®Google Scholar
• Antonenko YN, Avetisyan AV, Cherepanov DA, et al. Derivatives of rhodamine 19 as mild mitochondria-targeted cationic uncouplers. J Biol Chem 2011;286:17831–40.
   PubMed Web of Science ®Google Scholar
• Jara JA, Castro-Castillo V, Saavedra-Olavarria J, et al. Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice. J Med Chem 2014;57:2440–54.
   PubMed Web of Science ®Google Scholar
• Cortes LA, Castro L, Pesce B, et al. Novel gallate triphenylphosphonium derivatives with potent antichagasic activity. PLoS One 2015;10:e0136852.
   PubMed Web of Science ®Google Scholar
• Biasutto L, Sassi N, Mattarei A, et al. Impact of mitochondriotropic quercetin derivatives on mitochondria. Biochim Biophys Acta 2010;1797:189–96.
   PubMed Web of Science ®Google Scholar
• Lane DJ, Merlot AM, Huang ML, et al. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease. Biochim Biophys Acta 2015;1853:1130–44.
   PubMed Web of Science ®Google Scholar
• Andjelković M, Van Camp J, De Meulenaer B, et al. Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chem 2006;98:23–31.
   Web of Science ®Google Scholar
• Perron NR, Brumaghim JL. A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem Biophys 2009;53:75–100.
   PubMed Web of Science ®Google Scholar
• Reckziegel P, Dias VT, Benvegnu DM, et al. Antioxidant protection of gallic acid against toxicity induced by Pb in blood, liver and kidney of rats. Toxicol Report 2016;3:351–6.
   PubMed Web of Science ®Google Scholar
• Stanely Mainzen Prince P, Priscilla H, Devika PT. Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. Eur J Pharm 2009;615:139–43.
   PubMed Web of Science ®Google Scholar
• Bernardi P, Rasola A, Forte M, Lippe G. The mitochondrial permeability transition pore: channel formation by F-ATP synthase, integration in signal transduction, and role in pathophysiology. Physiol Rev 2015;95:1111–55.
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Moore G. Role of mitochondrial membrane permeability transition in p-hydroxybenzoate ester-induced cytotoxicity in rat hepatocytes. Biochem Pharmacol 1999;58:811–6.
   PubMed Web of Science ®Google Scholar
• Haouzi D, Cohen I, Vieira HL, et al. Mitochondrial permeability transition as a novel principle of hepatorenal toxicity in vivo. Apoptosis 2002;7:395–405.
   PubMed Web of Science ®Google Scholar
• Rao VK, Carlson EA, Yan SS. Mitochondrial permeability transition pore is a potential drug target for neurodegeneration. Biochim Biophys Acta 2014;1842:1267–72.
   PubMed Web of Science ®Google Scholar
• Ong SB, Samangouei P, Kalkhoran SB, Hausenloy DJ. The mitochondrial permeability transition pore and its role in myocardial ischemia reperfusion injury. J Mol Cell Cardiol 2015;78:23–34.
   PubMed Web of Science ®Google Scholar
• Assaly R, de Tassigny A, Paradis S, et al. Oxidative stress, mitochondrial permeability transition pore opening and cell death during hypoxia-reoxygenation in adult cardiomyocytes. Eur J Pharmacol 2012;675:6–14.
   PubMed Web of Science ®Google Scholar
• Sandmann BJ, Chien MH, Sandmann RA. Stability constants of calcium, magnesium and zinc gallate using a divalent ion-selective electrode. Anal Lett 1985;18:149–59.
   Web of Science ®Google Scholar
• Sun J, Ren DD, Wan JY, et al. Desensitizing mitochondrial permeability transition by ERK-cyclophilin D axis contributes to the neuroprotective effect of gallic acid against cerebral ischemia/reperfusion injury. Fron Pharmacol 2017;8:184.
   PubMed Web of Science ®Google Scholar
• Hong S, Pedersen PL. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol Mol Biol Rev 2008;72:590–641.
   PubMed Web of Science ®Google Scholar
• Ahmad Z, Laughlin TF. Medicinal chemistry of ATP synthase: a potential drug target of dietary polyphenols and amphibian antimicrobial peptides. Curr Med Chem 2010;17:2822–36.
   PubMed Web of Science ®Google Scholar
• Nanjundaiah SM, Annaiah HN, Dharmesh SM. Gastroprotective effect of ginger rhizome (zingiber officinale) extract: role of gallic acid and cinnamic acid in H(+), K(+)-ATPase/H. pylori Inhibition and anti-Oxidative Mechanism. Evid Based Complement Alternat Med 2011;2011:249487.
   PubMed Web of Science ®Google Scholar
• Bouayed J, Bohn T. Exogenous antioxidants–double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses. Oxid Med Cell Longev 2010;3:228–37.
   PubMed Web of Science ®Google Scholar